CIK 0001999480 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Alto Neuroscience, Inc.
Sign in to watch- Ticker
- ANRO
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 834210124
- Phone
- 773-255-5012
- Business address
- 650 CASTRO STREET, SUITE 450, MOUNTAIN VIEW, CA, 94041
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,567,247
- in 1 filing
Net −$3,567,247. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-02 | Smith Nicholas Conrad PRESIDENT AND CFO | Option exercise | +55,000 | $2.32 | $128K | 79,060 |
| 2026-10-02 | Smith Nicholas Conrad PRESIDENT AND CFO | Option exercise · Employee Stock Option (Right to Buy) | −55,000 | 57,405 | ||
| 2026-09-30 | Smith Nicholas Conrad PRESIDENT AND CFO | Option exercise | +24,056 | $2.35 | $57K | 48,116 |
| 2026-09-30 | Smith Nicholas Conrad PRESIDENT AND CFO | Sale | −23,170 | $25.78 | $597K | 24,946 |
| 2026-09-30 | Smith Nicholas Conrad PRESIDENT AND CFO | Sale | −886 | $26.87 | $24K | 24,060 |
| 2026-09-30 | Smith Nicholas Conrad PRESIDENT AND CFO | Option exercise · Employee Stock Option (Right to Buy) | −24,056 | 121,818 | ||
| 2026-09-29 | Smith Nicholas Conrad PRESIDENT AND CFO | Option exercise | +56,455 | $2.35 | $133K | 80,515 |
| 2026-09-29 | Smith Nicholas Conrad PRESIDENT AND CFO | Option exercise | +54,375 | $2.35 | $128K | 134,890 |
| 2026-09-29 | Smith Nicholas Conrad PRESIDENT AND CFO | Sale | −110,830 | $26.58 | $2.9M | 24,060 |
| 2026-09-29 | Smith Nicholas Conrad PRESIDENT AND CFO | Option exercise · Employee Stock Option (Right to Buy) | −56,455 | 145,874 | ||
| 2026-09-29 | Smith Nicholas Conrad PRESIDENT AND CFO | Option exercise · Employee Stock Option (Right to Buy) | −54,375 | 35,625 | ||
| 2026-05-27 | Miller Andrew Craig Director | Grant or award · Stock Option (right to buy) | +26,000 | 26,000 | ||
| 2026-05-14 | Etkin Amit PRESIDENT AND CEO | Gift | −400,000 | 833,949 | ||
| 2026-05-12 | Manji Husseini Director | Grant or award · Stock Option (right to buy) | +10,958 | 10,958 | ||
| 2026-05-12 | York Gwill Director | Grant or award · Stock Option (right to buy) | +10,958 | 10,958 | ||
| 2026-05-12 | Cox Christopher Nixon Director | Grant or award · Stock Option (right to buy) | +10,958 | 10,958 | ||
| 2026-05-12 | Sanchez Ramiro Director | Grant or award · Stock Option (right to buy) | +10,958 | 10,958 | ||
| 2026-05-12 | Dreyfus Andrew Director | Grant or award · Stock Option (right to buy) | +10,958 | 10,958 | ||
| 2026-03-01 | Smith Nicholas Conrad CHIEF FINANCIAL OFFICER & CBO | Shares withheld for taxes | −2,806 | $19.69 | $55K | 24,060 |
| 2026-03-01 | Etkin Amit PRESIDENT AND CEO | Shares withheld for taxes | −6,227 | $19.69 | $123K | 1,233,949 |
Page 1 of 7 · 125 trades